{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-067535","form_type":"8-K","ticker":"SXTP","cik":"0001946563","company_name":"60 DEGREES PHARMACEUTICALS, INC.","filed_at":"2024-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.251701+00:00","generated_at":"2026-05-31T10:10:26.185630+00:00","sec_items":["5.03","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"60 Degrees Pharmaceuticals effects 1:12 reverse stock split to regain Nasdaq compliance","bullets":["Reverse stock split at 1-for-12 ratio effective August 12, 2024; new CUSIP 83006G203.","Split aims to bring stock price above Nasdaq's $1.00 minimum bid requirement.","Stockholders approved reverse split range on July 16; Board set exact ratio on July 19.","No fractional shares issued; all fractional amounts rounded up to one whole share.","Common stock symbol SXTP unchanged; warrants symbol SXTPW unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-067535","json":"https://secwatch.observer/filing/0001213900-24-067535.json","markdown":"https://secwatch.observer/filing/0001213900-24-067535.md","text":"https://secwatch.observer/filing/0001213900-24-067535.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024067535/0001213900-24-067535-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024067535/ea0211125-8k_60degrees.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:10:26.185630+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}